DermTopic: Psoriasis

Filter Your Results

 

News

 

Ortho Dermatologics Announces Aspire Higher Scholarship Hono…

Ortho Dermatologics announced the nine recipients of the Aspire Higher Scholarship program, which honors the achievement…

Long-Term Use of Lilly's Taltz Shows Efficacy Improvements i…

Patients with active psoriatic arthritis (PsA) treated with Taltz (ixekizumab), who were previously intolerant or had in…

Study: PsO, RA Patients Prescribed Similar Drugs, But PsO Pa…

Compared to controls, patients with psoriasis (PsO) are at higher risk for serious liver disease than patients with rheu…

FDA Accepts Ortho Dermatologic’s NDA for Novel Plaque Psor…

The US Food and Drug Administration has accepted Ortho Dermatologic's New Drug Application (NDA) for IDP-118 (h…

Abbvie's Risankizumab Performs Well in Three Phase Three Pso…

Top-line results from three pivotal Phase 3 clinical trials show that  risankizumab, an investigational interleukin…

FDA Approves Janssen’s Golimumab for PsA, AS

  The FDA approved Janssen’s SIMPONI ARIA (golimumab) for the treatment of adults with active psoriat…

Ortho Dermatologics: Long-term Efficacy Data for Siliq

Siliq™ (brodalumab) injection provided sustained high levels of skin clearance (PASI 100) over more than two years…

FDA Approves Stelara for Treatment of Adolescents with Moder…

The FDA approved an expanded indication for Janssen Biotech, Inc.'s Stelara (ustekinumab) for the treatment of adole…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.